[Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research

August 20, 2020

[Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research by Ravi Iyer, Director GHEOR, TEVA Pharmaceuticals Inc.

Download here.

FDA Approves Groundbreaking CRISPR Gene-Editing Medicine for Sickle Cell Disease

December 8, 2023

Advancements and Challenges in GLP-1 Based Therapies for Diabetes and Obesity

Implementing Diversity Action Plans in Clinical Trials: Navigating FDA Requirements and Enhancing Inclusivity

December 7, 2023

Global Angiography Catheter Market: Surge in Demand Driven by Minimally Invasive Procedures and Cardiovascular Disease Prevalence

AbbVie Expands Neuroscience Portfolio with $8.7 Billion Acquisition of Cerevel Therapeutics

December 6, 2023

FDA Gives First Approval for Novartis’ Iptacopan, a Revolutionary Oral Treatment for Rare Blood Disorder PNH

[Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research

August 20, 2020

Share This Story!

Read Further

December 8, 2023

December 7, 2023

December 6, 2023